OCC 1.32% 38.5¢ orthocell limited

Ann: Ortho-ATI Shoulder Tendon Study Database Lock, page-139

  1. 1,602 Posts.
    lightbulb Created with Sketch. 167
    Don’t take it for granted that these long drawn out
    trial results will be as good as expected. Maybe
    they will be, maybe they won’t. So much has not
    gone smoothly with this company. Five times
    bitten, twice shy.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.